z-logo
open-access-imgOpen Access
Sialic Acid Is a Predictor of Cardiovascular Complications in Renal Transplantation Recipients
Author(s) -
Rafael Romero,
Xosé M. Lens,
D. Novoa,
V. Arcocha,
Rafael Alonso,
María Dolores Arza Arza,
Lucia Mouzo,
Manuel Posada de la Paz,
D. Sánchez-Guisande
Publication year - 1993
Publication title -
˜the œnephron journals/nephron journals
Language(s) - English
Resource type - Journals
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000187545
Subject(s) - medicine , transplantation , nephrology , sialic acid , renal transplant , cardiology , biochemistry , chemistry
Dr. Rafael Romero, Servicio de Nefrología, Hospital General de Galicia, Clínico Universitario, c/ Galeras s/n, E-15705 Santiago de Compostela (Spain) Fig. 1. SSA levels in the RTR group {W) and the control group (®). calculated creatinine clearance (r =-0.107) was found. More significant is the fact that 3 patients had an atherosclerotic vascular complication (1 stroke, 2 acute myocardial infarctions) 5-8 months after the study was done, and these 3 patients were in the 95th percen-tile of SSA level in the RTR group (SSA levels: 97, 97 and 105 mg/dl, respectively). Higher levels of SSA in RTR than in controls might be explained because of their lower renal function, but the lack of a clear correlation between SSA and creatinine or calculated creatinine clearance is against this hypothesis. We cannot exclude that SSA levDear Sir, Recently, Lindberg et al. [1] have identified a positive association between serum sialic acid (SSA) concentration and mortality from cardiovascular disease in a general population. Sialic acid is bound to the nonre-ducing end of carbohydrate chains of glyco-proteins and glycolipids. Some of these are called acute phase reactants and such substances rapidly increase in concentration after the onset of an inflammatory reaction or injury [2]. Although the cause of the association between SSA and mortality from cardiovascular disease is not known, a possible explanation of this fact is that SSA concentration may reflect the existence or the activity of an atherosclerotic process [1]. We have examined SSA concentration [3] in a group of 87 renal transplant recipients (RTR, 57 males, 30 females, age 40 ± 12.4, mean ± SD, years, time since transplantation more than 6 months, creatinine level 132 ± 59.2 μmol/l) treated with conventional therapy (prednisone, azathioprine and/or ci-closporin) and we have compared them with a group of 41 healthy subjects (29 males, 12 females, age 43 ± 13.8 years). SSA levels were higher in the RTR group in comparison with the control group (77 ± 10.5 mg/dl, range 55-105, versus 66 ± 9.3 mg/dl, range 44-81; p < 0.001, Mann-Whitney test), and

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom